NeuroSense Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.About NRSN
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS).
CEOAlon Ben-Noon
CEOAlon Ben-Noon
Employees15
Employees15
HeadquartersHerzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded2017
Founded2017
Employees15
Employees15
NRSN Key Statistics
Market cap27.93M
Market cap27.93M
Price-Earnings ratio-1.61
Price-Earnings ratio-1.61
Dividend yield—
Dividend yield—
Average volume382.26K
Average volume382.26K
High today—
High today—
Low today—
Low today—
Open price$0.94
Open price$0.94
Volume700.00
Volume700.00
52 Week high$2.60
52 Week high$2.60
52 Week low$0.6801
52 Week low$0.6801
Stock Snapshot
With a market cap of 27.93M, NeuroSense Therapeutics(NRSN) trades at $0.91. The stock has a price-to-earnings ratio of -1.61.
On 2026-01-23, NeuroSense Therapeutics(NRSN) shares started trading at $0.94, with intraday highs of — and lows of —.
Trading activity shows a volume of 700, compared to an average daily volume of 382.26K.
The stock's 52-week range extends from a low of $0.68 to a high of $2.60.
The stock's 52-week range extends from a low of $0.68 to a high of $2.60.
People also own
Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.